PolyNovo Biomaterials Pty

Closed portfolio snapshot

According to ClinicalTrials.gov-derived indexes, PolyNovo Biomaterials Pty sits in the upper quartile of US sponsors by registered trial count (#3,661 of 15,742 sponsors by registered trial count).

3 total trials none currently recruiting 1 completed upper quartile by trial count

PolyNovo Biomaterials Pty: 3 sponsored US clinical trials, none currently recruiting.

PolyNovo Biomaterials Pty sponsors 3 registered US clinical trials on ClinicalTrials.gov, none currently recruiting, and 1 completed. The most-studied condition in this pipeline is Burns, with 2 trials.

Upper-quartile sponsor footprint

PolyNovo Biomaterials Pty sits in the upper quartile of the sponsor corpus (#3,661 of 15,742 sponsors by registered trial count) - denser than most sponsors, still short of the top-decile hubs.

Indexed trials (enrollment closed)

3 total, page 1 of 1

ACTIVE NOT RECRUITING NA

Assessment of Safety and Effectiveness of NovoSorb® BTM in Severe Burns

NCT04090424
TERMINATED NA

Randomized Clinical Study Comparing SynPath to Standard of Care in Treatment of Chronic Diabetic Foot Ulcers

NCT05506215
COMPLETED NA

Assessment of Safety and Effectiveness of Biodegradable Temporizing Matrix in the Treatment of Deep Burn Skin Injuries

NCT02905435

Therapeutic Areas

Burns 2

How the PolyNovo Biomaterials Pty archive is shaped

3 indexed studies, none listed as recruiting (0% open); 1 completed (33%).

Phase labels are sparse on this sponsor index, so phase mix is not charted here.

Top condition: Burns (2 trials), 0 others listed.

How to read a closed sponsor archive

When recruiting_count is zero, the indexed set is completed or otherwise not open. Phase tilt still describes where archived studies sat on the investigational pathway. Re-check ClinicalTrials.gov before acting.

PolyNovo Biomaterials Pty: archived-pipeline peers nationwide

Peers matched on 3 indexed studies with no current recruiting: volume and archive shape, not condition overlap.

PolyNovo Biomaterials Pty sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot). 2×2 strategic matrix plotting 9 entities by Total trials (X) and Recruiting share (Y), with a crosshair dividing the plot into four quadrants. Higher volume & more openFocused & more openHigher volume, mostly closedSmaller & mostly closed 051015 0%0.0%0.0%0.1% Total trials Recruiting share PolyNovo Biomaterials Pty10xBio22nd Century GroupAA SecordAAADRS Clinical Research Center23andMe3-C Institute for Social Development3 Waves Wellness3EO Health
PolyNovo Biomaterials Pty sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together. Source: ClinicalTrials.gov (2026-08-08 snapshot).

PolyNovo Biomaterials Pty sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.

Sponsors near 3 archived trials

Sponsors with similar archive density (± trial count)

Related

Read our methodology - how this data is sourced, computed, and verified.

What to do with this PolyNovo Biomaterials Pty page

3 registered trials is a research-attention snapshot, not an endorsement of PolyNovo Biomaterials Pty or any single study.

  • None of PolyNovo Biomaterials Pty's trials are currently recruiting in this registry; that can change as new trials post, or check the broader research index. Browse research indexes
  • Burns is the condition PolyNovo Biomaterials Pty studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Burns trials
  • Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide

Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.

PolyNovo Biomaterials Pty pipeline card: 3 registered trials from official public datasets.Report a data error.